TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
46,302
|
57,244
|
50,646 |
| Financial expenses |
2,838
|
1,337
|
2,569 |
| Earnings before taxes |
2,083
|
2,493
|
3,067 |
| EBITDA |
6,933
|
7,361
|
9,076 |
| Total assets |
153,972
|
151,852
|
127,565 |
| Current assets |
71,271
|
62,326
|
34,517 |
| Current liabilities |
44,886
|
40,799
|
19,110 |
| Equity capital |
107,463
|
109,557
|
107,253 |
| - share capital |
27,614
|
28,586
|
28,503 |
| Employees (average) |
370
|
345
|
364 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.8%
|
72.1%
|
84.1% |
| Turnover per employee |
125
|
166
|
139 |
| Profit as a percentage of turnover |
4.5%
|
4.4%
|
6.1% |
| Return on assets (ROA) |
3.2%
|
2.5%
|
4.4% |
| Current ratio |
158.8%
|
152.8%
|
180.6% |
| Return on equity (ROE) |
1.9%
|
2.3%
|
2.9% |
| Change turnover |
-8,997
|
6,451
|
6,422 |
| Change turnover % |
-16%
|
13%
|
15% |
| Chg. No. of employees |
25
|
-19
|
14 |
| Chg. No. of employees % |
7%
|
-5%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.